These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9168159)
21. Two temporal stages of oligodendroglial response to excitotoxic lesion in the gray matter of the adult rat brain. Jamin N; Junier MP; Grannec G; Cadusseau J Exp Neurol; 2001 Nov; 172(1):17-28. PubMed ID: 11681837 [TBL] [Abstract][Full Text] [Related]
22. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. De Groot CJ; Ruuls SR; Theeuwes JW; Dijkstra CD; Van der Valk P J Neuropathol Exp Neurol; 1997 Jan; 56(1):10-20. PubMed ID: 8990125 [TBL] [Abstract][Full Text] [Related]
23. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Jäkel S; Agirre E; Mendanha Falcão A; van Bruggen D; Lee KW; Knuesel I; Malhotra D; Ffrench-Constant C; Williams A; Castelo-Branco G Nature; 2019 Feb; 566(7745):543-547. PubMed ID: 30747918 [TBL] [Abstract][Full Text] [Related]
24. Cellular reaction to an acute demyelinating/remyelinating lesion of the rat brain stem: localisation of GD3 ganglioside immunoreactivity. Reynolds R; Wilkin GP J Neurosci Res; 1993 Nov; 36(4):405-22. PubMed ID: 8271315 [TBL] [Abstract][Full Text] [Related]
25. Radiation-induced apoptosis in the neonatal and adult rat spinal cord. Li YQ; Wong CS Radiat Res; 2000 Sep; 154(3):268-76. PubMed ID: 10956432 [TBL] [Abstract][Full Text] [Related]
26. Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques. Solanky M; Maeda Y; Ming X; Husar W; Li W; Cook S; Dowling P J Neurosci Res; 2001 Aug; 65(4):308-17. PubMed ID: 11494366 [TBL] [Abstract][Full Text] [Related]
27. Apoptotic glial cell death and kinetics in the spinal cord of the myelin-deficient rat. Lipsitz D; Goetz BD; Duncan ID J Neurosci Res; 1998 Feb; 51(4):497-507. PubMed ID: 9514203 [TBL] [Abstract][Full Text] [Related]
28. Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model. Romanelli E; Merkler D; Mezydlo A; Weil MT; Weber MS; Nikić I; Potz S; Meinl E; Matznick FE; Kreutzfeldt M; Ghanem A; Conzelmann KK; Metz I; Brück W; Routh M; Simons M; Bishop D; Misgeld T; Kerschensteiner M Nat Commun; 2016 Nov; 7():13275. PubMed ID: 27848954 [TBL] [Abstract][Full Text] [Related]
29. NG2 positive cells of rat spinal cord activated during experimental autoimmune encephalomyelitis are spatially associated with radially oriented astroglia and express p75 receptor: a role for nerve growth factor in oligodendrocyte progenitor migration? Oderfeld-Nowak B; Zaremba M; Kwiatkowska-Patzer B; Lipkowski AW; Kurkowska-Jastrzebska I; Triaca V; Aloe L Arch Ital Biol; 2009 Dec; 147(4):105-15. PubMed ID: 20162860 [TBL] [Abstract][Full Text] [Related]
30. Minisegments of newborn rat optic nerves in vitro: gliogenesis and myelination. Omlin FX; Waldmeyer J Exp Brain Res; 1986; 65(1):189-99. PubMed ID: 2433143 [TBL] [Abstract][Full Text] [Related]
32. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis. Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992 [TBL] [Abstract][Full Text] [Related]
33. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Wolswijk G Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125 [TBL] [Abstract][Full Text] [Related]
34. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis. Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039 [TBL] [Abstract][Full Text] [Related]
35. [Pathology and pathogenesis of multiple sclerosis from the viewpoint of neurologic disease research]. Seitelberger F Wien Med Wochenschr; 1985 Jan; 135(1-2):6-7. PubMed ID: 3976241 [TBL] [Abstract][Full Text] [Related]
36. Evidence for central nervous system glial cell plasticity in phenylketonuria. Dyer CA; Kendler A; Philibotte T; Gardiner P; Cruz J; Levy HL J Neuropathol Exp Neurol; 1996 Jul; 55(7):795-814. PubMed ID: 8965095 [TBL] [Abstract][Full Text] [Related]
37. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination. Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410 [TBL] [Abstract][Full Text] [Related]
38. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396 [TBL] [Abstract][Full Text] [Related]
39. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Raine CS; Scheinberg L; Waltz JM Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526 [TBL] [Abstract][Full Text] [Related]
40. Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis? Cui QL; Khan D; Rone M; T S Rao V; Johnson RM; Lin YH; Bilodeau PA; Hall JA; Rodriguez M; Kennedy TE; Ludwin SK; Antel JP Ann Neurol; 2017 Jun; 81(6):811-824. PubMed ID: 28470695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]